Cresco Labs, Inc. (CRLBF)
1.09
-0.02
(-1.80%)
USD |
OTCM |
Feb 20, 12:12
Cresco Labs EPS Diluted (Quarterly) : -0.048 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.4072 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.97M |
| Revenue (Quarterly) | 164.91M |
| Total Expenses (Quarterly) | 181.97M |
| Enterprise Value | 810.62M |
| Gross Profit Margin (Quarterly) | 45.06% |
| Profit Margin (Quarterly) | -13.32% |
| Earnings Yield | -13.56% |
| Operating Earnings Yield | 21.87% |
| Normalized Earnings Yield | -7.339 |